NCT00882154View on ClinicalTrials.gov

To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 300 mg Capsule Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
Healthy
Interventions
DRUG

Cefdinir 300 mg Capsule (Sandoz, Austria)

DRUG

Omnicef Cefdinir 300 mg Capsule (Abbott Laboratories, USA)

Sponsors

Lead Sponsor

Sandoz
All Listed Sponsors
lead

Sandoz

INDUSTRY